Friday, 4 March 2016

Cancer study identifies likely responders to immune therapy

Cancer study identifies likely responders to immune therapy

The newest cancer therapies don’t work on everyone. Now, doctors have a clue why When neoantigens are found throughout a tumor, patients have the best shot at benefitting from immunotherapy drugs like Keytruda and Yervoy.

Continue to article and discussion...

No comments:

Post a Comment